Literature DB >> 10553389

Progress in coverage with hepatitis B vaccine among US children, 1994-1997.

H R Yusuf1, V G Coronado, F A Averhoff, E F Maes, L E Rodewald, M P Battaglia, F J Mahoney.   

Abstract

OBJECTIVES: This study was done to assess progress in hepatitis B vaccination of children from 1994 through 1997.
METHODS: We used data from the National Immunization Survey (NIS), a random-digit-dialed telephone survey that includes a mail survey to verify vaccination providers' records. The NIS is conducted in 78 geographic areas (50 states and 28 selected urban areas) in the United States.
RESULTS: A total of 32,433 household interviews were completed in the 1997 NIS. An estimated 83.7% of children aged 19 to 35 months received 3 or more doses of hepatitis B vaccine. Coverage with 3 doses was greater (86.7%) among children in states that had day care entry requirements for hepatitis B vaccination than among children in states without such requirements (83.0%) and was greater among children from families with incomes at or above the poverty level (85.0%) than among children below the poverty level (80.6%). Hepatitis B vaccination of children increased from 1994 through 1996, from 41% to 84%, but coverage reached a constant level of 84% to 85% in 1996/97.
CONCLUSION: Although substantial progress has been made in fully vaccinating children against hepatitis B, greater efforts are needed to ensure that all infants receive 3 doses of hepatitis B vaccine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553389      PMCID: PMC1508968          DOI: 10.2105/ajph.89.11.1684

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991 through 1994. Connecticut Hepatitis B Project Group.

Authors:  B A Woodruff; J Stevenson; H Yusuf; S L Kwong; K P Todoroff; J L Hadler; M A Hoyt; F J Mahoney
Journal:  Pediatrics       Date:  1996-06       Impact factor: 7.124

2.  Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994.

Authors:  C W LeBaron; M Chaney; A L Baughman; E F Dini; E Maes; V Dietz; R Bernier
Journal:  JAMA       Date:  1997-02-26       Impact factor: 56.272

3.  A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives.

Authors:  B J McMahon; E R Rhoades; W L Heyward; E Tower; D Ritter; A P Lanier; R B Wainwright; C Helminiak
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

4.  Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?

Authors:  T G Ganiats; M T Bowersox; L P Ralph
Journal:  J Fam Pract       Date:  1993-02       Impact factor: 0.493

5.  Reactions of pediatricians to a new Centers for Disease Control recommendation for universal immunization of infants with hepatitis B vaccine.

Authors:  G L Freed; W C Bordley; S J Clark; T R Konrad
Journal:  Pediatrics       Date:  1993-04       Impact factor: 7.124

6.  Discussion of Immunization Practices Advisory Committee/American Academy of Pediatrics recommendations for universal infant hepatitis B vaccination.

Authors:  N A Halsey
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

Review 7.  Impact of hepatitis B virus infection on women and children.

Authors:  C N Shapiro; H S Margolis
Journal:  Infect Dis Clin North Am       Date:  1992-03       Impact factor: 5.982

8.  Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission.

Authors:  C E Stevens; P E Taylor; M J Tong; P T Toy; G N Vyas; P V Nair; J Y Weissman; S Krugman
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

9.  The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations.

Authors:  D E Pathman; T R Konrad; G L Freed; V A Freeman; G G Koch
Journal:  Med Care       Date:  1996-09       Impact factor: 2.983

10.  Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.

Authors:  Y Poovorawan; S Sanpavat; W Pongpunlert; S Chumdermpadetsuk; P Sentrakul; A Safary
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

View more
  3 in total

1.  A middle school immunization law rapidly and substantially increases immunization coverage among adolescents.

Authors:  Francisco Averhoff; Leslie Linton; K Michael Peddecord; Christine Edwards; Wendy Wang; Daniel Fishbein
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

2.  Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men.

Authors:  D A MacKellar; L A Valleroy; G M Secura; W McFarland; D Shehan; W Ford; M LaLota; D D Celentano; B A Koblin; L V Torian; H Thiede; R S Janssen
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

3.  A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City.

Authors:  Benny J Kottiri; Samuel R Friedman; Gary L Euler; Peter L Flom; Milagros Sandoval; Alan Neaigus; Don C Des Jarlais; Jonathan M Zenilman
Journal:  J Urban Health       Date:  2005-07-20       Impact factor: 3.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.